Search results
Found 315 matches for
In research published in the journal Virus Evolution, scientists from Oxford University’s Department of Zoology have revealed that Next-Generation Sequencing and its associated online DNA databases could be used in the field of viral discovery.
Nigeria rolls out new Oxford R21 malaria vaccine
18 October 2024
On Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M™ malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country’s fight against the deadly disease.
Developing the first cancer prevention vaccine for Lynch syndrome
10 September 2024
Scientists from the Centre for Human Genetics at Nuffield Department of Medicine are taking the initial steps in developing the UK’s first vaccine to prevent cancer in people with Lynch syndrome, thanks to funding from Cancer Research UK.
PSI collaborates with Oxford's History of Science Museum on new exhibition
12 August 2024
The Pandemic Sciences Institute, in collaboration with the Ethox Centre, has supported a new exhibition at Oxford’s History of Science Museum. The exhibition, entitled "A Healthy Future for All?", explores the science driving advancements in healthcare
Côte d’Ivoire becomes first nation to deploy R21 malaria vaccine
16 July 2024
Côte d’Ivoire will become the first country to roll-out the new R21/Matrix-M™ vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.
Caesar Atuire appointed International Association of Bioethics President
6 June 2024
Many congratulations to Dr Caesar Atuire who has been appointed President of the International Association of Bioethics.
Bangladesh Health Minister visits the Centre for Medicines Discovery
27 May 2024
The Minister of Health and Family Welfare of Bangladesh, the Honourable Dr Samanta Lal Sen, and the Bangladesh High Commissioner to the UK, Her Excellency Ms Saida Muna Tasneem, paid a visit to the Centre for Medicines Discovery at NDM last week.
Pandemic computer simulations to guide future vaccine trials
23 May 2024
Researchers from the Pandemic Sciences Institute at NDM are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
Academy of Medical Sciences elects two NDM researchers as new Fellows
21 May 2024
The Academy of Medical Sciences has elected two medical scientists from the Nuffield Department of Medicine to its fellowship in 2024.
NDM scientists elected as Royal Society Fellows
16 May 2024
Two academics from the Nuffield Department of Medicine have joined the Royal Society as Fellows.
Prof Yang Shi elected to the US National Academy of Sciences
3 May 2024
Professor Yang Shi from the Ludwig Institute for Cancer Research at NDM has been elected as a member of the National Academy of Sciences in the United States.
Melanoma research in the Ludwig Institute for Cancer Research
2 May 2024
For Skin Cancer Awareness Month, the Ludwig Institute for Cancer Research looks at recent research into melanoma from Professors Richard White, Professor of Genetics, and Colin Goding, Professor of Oncology.
Unveiling of Medawar Nobel Prize medal
30 April 2024
The Oxford immunology community celebrated the donation of Sir Peter Medawar’s Nobel Prize medal to the University.
Record number of patients enrolled in a landmark plague trial
29 April 2024
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
The potential of the R21/Matrix vaccine to redefine malaria prevention
25 April 2024
Researchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.
Chinese ambassador visits CAMS Oxford Institute
15 April 2024
The Chinese Ambassador to the United Kingdom, His Excellency Zheng Zeguang, visited the University of Oxford last week, where he promoted deeper educational exchanges between China and the UK. During the visit, Zheng met with Irene Tracey, Vice-Chancellor of the university, and had an in-depth discussion on the university’s collaboration with Chinese counterparts.
Francesco Boccellato receives Lee Placito Research Fellowship
8 April 2024
Dr Francesco Boccellato, Leadership Fellow at the Oxford Branch of the Ludwig Institute for Cancer Research has recently been awarded the Lee Placito Research Fellowship in Gastrointestinal Cancer.
Oxford hosts Belgian vaccine experts
5 April 2024
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
OUCRU celebrates World Health Worker Week 2024
4 April 2024
In the first week of April each year, the global community comes together to celebrate health workers, the backbone of the health industry and society.
Developing the world's first lung cancer vaccine
26 March 2024
Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.
CMD partners with Ono Pharmaceutical Co for translational research
25 March 2024
The Centre for Medicines Discovery (CMD) at NDM, has recently partnered with Ono Pharmaceutical Co (Ono) to validate and develop novel targets in a bid to discover innovative medicines.